Carcinoma News and Research

RSS
Carcinoma is cancer that begins in the skin or in tissues that line or cover internal organs.
Webinar: Latest updates on percutaneous and transcatheter treatment of liver, kidney and lung tumor ablation

Webinar: Latest updates on percutaneous and transcatheter treatment of liver, kidney and lung tumor ablation

Rice University's new BRC awarded $2M NIH grant to develop an inexpensive test for oral cancer

Rice University's new BRC awarded $2M NIH grant to develop an inexpensive test for oral cancer

ArQule reports financial results for the fiscal quarter and nine months ended September 30, 2009

ArQule reports financial results for the fiscal quarter and nine months ended September 30, 2009

Alnylam Pharmaceuticals presents new data related to its overall delivery research efforts

Alnylam Pharmaceuticals presents new data related to its overall delivery research efforts

Advanced equipment targets radiation to specific areas in the brain

Advanced equipment targets radiation to specific areas in the brain

Switching to new immunosuppressant drug may reduce skin cancer after kidney transplantation

Switching to new immunosuppressant drug may reduce skin cancer after kidney transplantation

Heidelberg Ion Radiation Therapy Center established; European patients can benefit from new radiation therapy

Heidelberg Ion Radiation Therapy Center established; European patients can benefit from new radiation therapy

Third-quarter 2009 financial results of Antigenics announced

Third-quarter 2009 financial results of Antigenics announced

UCSF receives $6.5 million gift from philanthropists Irwin and Joan Jacobs of La Jolla

UCSF receives $6.5 million gift from philanthropists Irwin and Joan Jacobs of La Jolla

Liquid-based cytology is not better than Pap tests for detecting cervical cancer

Liquid-based cytology is not better than Pap tests for detecting cervical cancer

First Japanese patient treated in Celsion’s global Phase III ThermoDox HEAT trial

First Japanese patient treated in Celsion’s global Phase III ThermoDox HEAT trial

BioSphere submits an IDE to the FDA for its QuadraSphere Microsphere product

BioSphere submits an IDE to the FDA for its QuadraSphere Microsphere product

International experts discuss ion radiation therapy

International experts discuss ion radiation therapy

Some colonoscopic technologies better at improving detection of adenomas

Some colonoscopic technologies better at improving detection of adenomas

Comprehensive, risk-based screening guidelines for breast, cervical and colorectal cancers

Comprehensive, risk-based screening guidelines for breast, cervical and colorectal cancers

Study reveals LOAD therapy can eliminate bacterium in patients with gastritis and peptic ulcers

Study reveals LOAD therapy can eliminate bacterium in patients with gastritis and peptic ulcers

National campaign to raise awareness of actinic keratosis

National campaign to raise awareness of actinic keratosis

Archexin has potential to target and treat multiple life-threatening cancers, finds new study

Archexin has potential to target and treat multiple life-threatening cancers, finds new study

New guidelines from American Academy of Dermatology for treatment of psoriasis with ultraviolet light therapy

New guidelines from American Academy of Dermatology for treatment of psoriasis with ultraviolet light therapy

Rosetta Genomics, GTG sign exclusive distribution agreement

Rosetta Genomics, GTG sign exclusive distribution agreement

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.